Brief: NeuroVive Program Granted ODD By The European Commission

Abliva AB

13/12/2017 07:30

Dec 13 (Reuters) - Neurovive Pharmaceutical Ab  NVP.ST : 
    * NEUROVIVE'S KL1333 PROGRAM GRANTED ORPHAN DRUG DESIGNATION 
BY 
THE EUROPEAN COMMISSION 
 
Source text for Eikon:  ID:nWkr282gCT  
Further company coverage:  NVP.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))